Baird Financial Group
TXG icon

Baird Financial Group’s 10x Genomics TXG Stock Holding History

Baird Financial Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,732
Closed -$258K – 1936
2021
Q4 		$258K Hold
1,732
– – ﹤0.01% 1732
2021
Q3 		$252K Buy
1,732
+15
+0.9% +$2.58K ﹤0.01% 1726
2021
Q2 		$336K Sell
1,717
-345
-17% -$62.4K ﹤0.01% 1547
2021
Q1 		$373K Buy
2,062
+345
+20% +$59.6K ﹤0.01% 1449
2020
Q4 		$243K Hold
1,717
– – ﹤0.01% 1445
2020
Q3 		$214K Buy
+1,717
New +$180K ﹤0.01% 1393

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baird Financial Group's TXG Position: Q1 2022 in Review

Baird Financial Group sold out of 10x Genomics (TXG) in Q1 2022, closing a stake of 1,732 shares — an estimated $258K sold.

Baird Financial Group first reported a position in TXG in Q3 2020 and held it in 6 quarters. The position peaked at $373K in Q1 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.

  • Baird Financial Group reported no remaining 10x Genomics position as of Q1 2022 after selling out during the quarter.
  • Baird Financial Group sold 1,732 10x Genomics shares in Q1 2022, an estimated $258K.
  • Baird Financial Group first reported a position in 10x Genomics in Q3 2020 and held it in 6 quarters.
  • Baird Financial Group's 10x Genomics position peaked at $373K in Q1 2021.
  • 314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.

Based on Baird Financial Group's 13F filing for Q1 2022, filed 13 May 2022.